Skip to content

Drug MonographTirzepatide · GLP-1·GIP

TirzepatideReport
Sections

Tirzepatide monograph · Evidence review

Missed a Tirzepatide Dose? The FDA 4-Day Rule, Explained

Missed your weekly Zepbound or Mounjaro shot? The FDA label rule: take it within 4 days (96 hours), skip it if more time has passed, and never double up.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

It happens to almost everyone on a weekly injection eventually: the day comes and goes, and you realize you forgot your shot. With tirzepatide — sold as Zepbound for weight management and Mounjaro for type 2 diabetes — there is a clear, official rule for exactly this situation, and it removes the guesswork. The FDA prescribing information spells out what to do, and the single most important thing to know is that you should never take two doses to "catch up."

This is general education tied to the FDA label, not personal medical advice. The patient Instructions for Use in your box and your prescriber are the final word for your situation1.

The 4-day rule, straight from the label

The Zepbound prescribing information states it plainly: if a dose is missed, administer it as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take the next dose on your regularly scheduled day1. The Mounjaro label carries the same once-weekly drug, and the same titration framework2.

In other words, the deadline is four days. Inside that window, take it and carry on. Outside it, let it go and resume your normal weekly rhythm — you do not restart the schedule or change anything else.

§ Missed Dose — FDA Prescribing Information

Missed your weekly dose

How many days have passed?

≤ 4 days (96 h): take it now

Then resume your normal weekly schedule

> 4 days: skip it

Take the next dose on your scheduled day

Never double up

Keep ≥72 h between any two doses

Source: Zepbound Prescribing Information, DailyMed SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b (Dosage and Administration: Missed Dose).

After you take a late dose: resetting your weekly day

There's a wrinkle people miss. If you take a forgotten dose a few days late, your "anchor day" may shift, and the label has a guardrail for that too. The Zepbound label allows you to change the day of weekly administration if necessary, as long as at least 3 days (72 hours) separate two doses1.

So if your normal day is Sunday, you forgot, and you take it on Tuesday (within the 4-day window), you now have a choice. You can either keep injecting on Tuesdays going forward, or move back toward Sunday — but only if your next Sunday shot would still be at least 72 hours after that Tuesday dose. The 72-hour floor exists to stop two doses from landing too close together. When in doubt, the simpler path is to make the new day your day, since any consistent weekly day is fine. (For why no day or hour is pharmacologically "better," see the best time and day to inject tirzepatide.)

The rule that matters most: never double up

The one mistake to avoid is taking two doses close together to make up for a missed one. The label's missed-dose instruction is to take the single missed dose within the window or skip it — not to add it on top of your next scheduled dose1. Doubling up is what the 72-hour minimum-spacing rule is designed to prevent.

Why does this matter so much? Tirzepatide's side effects are dose-dependent, and the gastrointestinal effects — nausea, vomiting, diarrhea — are most pronounced when blood levels of the drug rise34. Stacking two doses too close together effectively spikes your exposure and can provoke exactly the severe GI symptoms the slow, four-week titration schedule is built to avoid3. There is no benefit to "catching up" on lost drug, and a real risk of making yourself sick. One missed weekly dose of a long-acting drug is not a crisis; an accidental double dose can be.

§ Key Rules at a Glance

Tirzepatide missed-dose rules

  • Within 4 days (96 hours): take the missed dose, then continue as normal.
  • More than 4 days late: skip it and take the next dose on schedule.
  • Never take two doses together to make up for a missed one.
  • Keep at least 72 hours between any two doses if you shift your day.
  • One missed week is a small dip, not a crisis — the drug's ~5-day half-life keeps levels up.
Sources: Zepbound PI (DailyMed SetID 487cd7e7) for the missed-dose and day-change rules; Mounjaro PI (DailyMed SetID d2d7da5d) for the ~5-day half-life.

Why one missed week isn't a disaster

Here's the reassuring pharmacology. Tirzepatide has an elimination half-life of about 5 days, and steady-state levels build over roughly the first 4 weeks of weekly dosing2. Because the drug is long-acting and lingers, the medicine from last week's injection is still substantially present when this week's dose is due. A single late or skipped dose causes only a gentle dip in your levels, not a sudden cliff.

That's very different from a fast-acting daily medication, where a missed dose leaves a same-day gap. With a once-weekly, slow-clearing drug, missing one shot — and correctly skipping it if you're past the 4-day window — has a modest, temporary effect. The trials that produced tirzepatide's large results were built on consistent weekly dosing over many months5, so the goal is steady adherence over time, not panic over a single lapse.

The flip side: don't make missed doses a habit

The flip side of "one miss is fine" is that the pattern matters. The pivotal weight-loss results came from people who stayed on therapy, and SURMOUNT-4 showed that stopping tirzepatide leads to substantial weight regain — people who came off after titrating up regained much of what they'd lost, while those who continued kept the result6. Repeated missed doses drift toward that "stopping" scenario.

So treat the 4-day rule as a safety net for the occasional slip, not a routine. If you find yourself missing doses often, the practical fixes are mundane but effective:

  • Set a recurring weekly reminder for your injection day — the drug's slow rhythm makes a missed shot easy to overlook.
  • Anchor the shot to a habit you rarely skip (a weekly meal, a Sunday routine).
  • Keep your pens visible and correctly stored so "I forgot where it was" never becomes the reason.

When to call your clinician

A single missed dose handled by the 4-day rule needs no phone call. But reach out to your prescriber or pharmacist if:

  • You've missed several weeks in a row and aren't sure whether to resume at your current dose or step back down — long gaps can reduce your tolerance to the dose, and your clinician may want to re-titrate.
  • You accidentally took a double dose and develop severe or persistent nausea, vomiting, or dehydration — these are the dose-dependent GI effects the spacing rules exist to prevent3.
  • You're unsure which strength pen you should be on after a gap.

When in doubt, the label and your care team beat any general rule of thumb.

The honest bottom line

Missed a tirzepatide dose? The FDA rule is simple: take it within 4 days (96 hours); if more than 4 days have passed, skip it and resume your normal weekly schedule — and never take two doses to catch up1. If a late dose shifts your day, you can change your weekly day as long as 72 hours separate two doses1. Because tirzepatide is long-acting (a ~5-day half-life), one missed week causes only a small dip, not a crisis2 — but consistent dosing is what drives and holds results56. For the full schedule, see the tirzepatide dosage chart; for injection technique, how and where to inject Zepbound; for the broader evidence, the tirzepatide evidence guide; and to weigh how to get it, our best tirzepatide overview.

Frequently asked questions

What should I do if I miss a tirzepatide dose?

Per the FDA label, take the missed dose as soon as possible within 4 days (96 hours) of when it was due, then continue your normal weekly schedule. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Never take two doses to catch up.

Can I take two tirzepatide doses to make up for a missed one?

No. The label's rule is to take the single missed dose within the 4-day window or skip it — never to add it on top of your next scheduled dose. Doubling up spikes your drug exposure and can trigger severe nausea, vomiting, and diarrhea, which is exactly what the minimum 72-hour spacing between doses is designed to prevent.

How late can I take my tirzepatide injection?

Up to 4 days (96 hours) late. Within that window, take it as soon as you remember. Beyond 4 days, skip it and resume your normal weekly schedule. If taking a late dose shifts your day, you can change your weekly injection day as long as at least 72 hours separate the two doses.

Will one missed dose ruin my progress?

No. Tirzepatide is long-acting, with an elimination half-life of about 5 days, so the medicine from your last shot is still largely present when the next is due. One missed week causes only a small, temporary dip — not a cliff. Consistent dosing over months is what drives results, so an occasional miss handled by the 4-day rule is not a setback.

What if I've missed tirzepatide for several weeks?

Call your prescriber or pharmacist. After a long gap your tolerance to your current dose may drop, and your clinician may want to restart at a lower dose and re-titrate up to avoid a flare of gastrointestinal side effects. Don't simply resume your highest dose after weeks off without checking.

References(6)

  1. Eli Lilly and Company (FDA prescribing information via DailyMed) (2026). ZEPBOUND (tirzepatide) injection, for subcutaneous use — Prescribing Information & Instructions for Use (Dosage and Administration: Missed Dose; Important Administration Instructions).. DailyMed (U.S. National Library of Medicine), SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  2. Eli Lilly and Company (FDA prescribing information via DailyMed) (2025). MOUNJARO (tirzepatide) injection, for subcutaneous use — Prescribing Information (Dosage and Administration; Clinical Pharmacology 12.3: half-life ~5 days; steady state by 4 weeks).. DailyMed (U.S. National Library of Medicine), SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  3. Lin F, Yu B, Ling B, Lv G, Shang H, Zhao X, Jie X, Chen J, Li Y (2023). Weight loss efficiency and safety of tirzepatide: A Systematic review.. PLoS One. PMID: 37141329. https://pubmed.ncbi.nlm.nih.gov/37141329/
  4. Qin W, Yang J, Ni Y, Deng C, Ruan Q, Ruan J, Zhou P, Duan K (2024). Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial.. Endocrine. PMID: 38850440. https://pubmed.ncbi.nlm.nih.gov/38850440/
  5. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  6. Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA, and the SURMOUNT-4 Investigators (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.. JAMA. PMID: 38078870. https://pubmed.ncbi.nlm.nih.gov/38078870/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related monograph sections